New York-based pharmaceuticals company Inovio Pharma said on Wednesday that it is planning to expand its pharmaceutical operations in the US in the near future.
The company is set to open a new office in Cleveland, Ohio, in early 2021.
It has also plans to expand operations in Los Angeles and Miami.
Inovio is the parent company of Inovios Therapeutics, which is owned by private equity firm Apollo Global Management.
It is the world’s fourth-largest producer of biologics.
Earlier this month, Inoviol Pharmaceuticals announced it would expand its drug pipeline in the United States, and said it is currently looking to open two new centers in Cleveland.
Inoviat Pharma also plans new expansion plans in the coming months.